Choline c-11
Choline c-11 is a small molecule pharmaceutical. Choline c-11 was first approved as Choline c-11 on 2012-09-12.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Choline c-11
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CHOLINE C-11 | Mayo Clinic PET Radiochemistry Facility | N-203155 RX | 2012-09-12 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| choline c 11 | New Drug Application | 2022-01-25 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| A9515 | Choline c-11, diagnostic, per study dose up to 20 millicuries |
Clinical
Clinical Trials
52 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Surgical wound infection | D013530 | — | 2 | — | 6 | — | 8 | ||
| Infections | D007239 | EFO_0000544 | — | — | — | 4 | 3 | 7 | |
| Wound infection | D014946 | — | 1 | 1 | 1 | 1 | 3 | ||
| Appendicitis | D001064 | EFO_0007149 | K37 | — | — | — | 1 | 1 | 2 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | 1 | 1 | 2 |
| Post-lyme disease syndrome | D000077342 | — | — | — | 1 | — | 1 | ||
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | 1 | — | 1 |
| Wounds and injuries | D014947 | T14.8 | — | — | — | 1 | — | 1 | |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | 1 | — | 1 |
| Streptococcal infections | D013290 | EFO_1001476 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Endophthalmitis | D009877 | 1 | 1 | — | — | 2 | 3 | ||
| Antibiotic prophylaxis | D019072 | — | 2 | — | — | — | 2 | ||
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
| Sinusitis | D012852 | EFO_0007486 | J32 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Communicable diseases | D003141 | — | — | — | — | 2 | 2 | ||
| Erythema chronicum migrans | D015787 | A26.0 | — | — | — | — | 1 | 1 | |
| Chemical and drug induced liver injury | D056486 | — | — | — | — | 1 | 1 | ||
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | — | — | 1 | 1 |
| Critical illness | D016638 | — | — | — | — | 1 | 1 | ||
| Sepsis | D018805 | A41.9 | — | — | — | — | 1 | 1 | |
| Septic shock | D012772 | A48.3 | — | — | — | — | 1 | 1 | |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | — | 1 | 1 | |
| Pregnancy complications | D011248 | — | — | — | — | 1 | 1 | ||
| Cataract | D002386 | EFO_0001059 | H26.9 | — | — | — | — | 1 | 1 |
Show 6 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | CHOLINE C-11 |
| INN | — |
| Description | (11)C-choline chloride is a quaternary ammonium salt that is the chloride salt of (11)C-choline. An intravenous radioactive diagnostic agent used as a tracer during positron emission tomography scans to help detect sites of recurrent prostate cancer. It has a role as a radioactive tracer, a radioactive imaging agent and a diagnostic agent. It is a chloride salt, a quaternary ammonium salt and an (11)C-modified compound. It contains an (11)C-choline. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | C[N+](C)([11CH3])CCO.[Cl-] |
Identifiers
| PDB | — |
| CAS-ID | 87591-54-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2095207 |
| ChEBI ID | 72321 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,842 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more